Torrent Pharma, a flagship company of the Torrent Group, stands as one of the foremost pharmaceutical firms in the country. Notably, the company played a pioneering role in introducing niche marketing in India.
Furthermore, Torrent Pharma has established a significant presence in diverse medical fields. The company’s competitive edge lies in its world-class manufacturing facilities, advanced research and development capabilities, extensive domestic network, and global outreach spanning across more than 40 countries.
It stands as a prominent Indian pharmaceutical company actively involved in the research, development, manufacturing, and marketing of generic pharmaceutical formulations.
This article aims to explore the share price target of Torrent Pharmaceuticals from 2024 to 2030, as well as analyze the viability of Torrent Pharmaceuticals as a promising stock to consider for investment.
HOW TO BUY TORRENT PHARMACEUTICALS SHARES ?
You can buy Torrent Pharmaceuticals shares from the following trading platforms:
- Zerodha
- Upstox
- Groww
- AngleOne
- ICICIDirect
SHARE PRICE PREDICTION OF TORRENT PHARMACEUTICALS :2024, 2025 TO 2030
SHARE PRICE TARGET 2024 OF TORRENT PHARMACEUTICALS
| When | Maximum Price | Minimum Price |
| February 2024 | 2,717.00 | 2,362.61 |
| March 2024 | 2,772.45 | 2,410.83 |
| April 2024 | 2,691.70 | 2,340.61 |
| May 2024 | 2,651.92 | 2,306.02 |
| June 2024 | 2,747.39 | 2,389.03 |
| July 2024 | 2,719.91 | 2,365.14 |
| August 2024 | 2,828.71 | 2,459.75 |
| September 2024 | 2,941.86 | 2,558.14 |
| October 2024 | 2,884.18 | 2,507.98 |
| November 2024 | 2,970.70 | 2,583.22 |
| December 2024 | 3,044.97 | 2,647.80 |
In 2024, the commodity is expected to experience fluctuating prices. February is projected to have a range of 2,717.00 to 2,362.61, followed by March with prices varying between 2,772.45 and 2,410.83. April is anticipated to see prices within the range of 2,691.70 to 2,340.61.
Moving forward, May is projected to have a maximum of 2,651.92 and a minimum of 2,306.02. June is expected to witness a range of 2,747.39 to 2,389.03. July will likely see prices fluctuating between 2,719.91 and 2,365.14.
August is projected to have a maximum of 2,828.71 and a minimum of 2,459.75. September’s range is expected to be 2,941.86 to 2,558.14, while October is projected to see prices between 2,884.18 and 2,507.98.
In November, prices are anticipated to vary from 2,970.70 to 2,583.22, and December is expected to witness a range of 3,044.97 to 2,647.80.
SHARE PRICE TARGET 2025 OF TORRENT PHARMACEUTICALS
| When | Maximum Price | Minimum Price |
| January 2025 | ₹2,850.38 | ₹2,192.60 |
| February 2025 | ₹3,000.40 | ₹2,308.00 |
| March 2025 | ₹3,150.42 | ₹2,423.40 |
| April 2025 | ₹2,812.87 | ₹2,163.75 |
| May 2025 | ₹2,557.16 | ₹1,967.04 |
| June 2025 | ₹2,812.87 | ₹2,163.75 |
| July 2025 | ₹2,678.93 | ₹2,060.71 |
| August 2025 | ₹2,790.55 | ₹2,146.58 |
| September 2025 | ₹2,930.08 | ₹2,253.91 |
| October 2025 | ₹3,105.88 | ₹2,389.14 |
| November 2025 | ₹3,323.29 | ₹2,556.38 |
| December 2025 | ₹3,389.76 | ₹2,607.51 |
In 2025, Torrent Pharmaceuticals is projected to witness fluctuations in its share price, providing potential opportunities and challenges for investors. The share price target for the company varies throughout the year, with a minimum price of ₹1,967.04 in May and a maximum price of ₹3,389.76 in December.
Assessing the growth percentage for 2025, we observe that the share price begins at ₹2,192.60 in January and culminates at ₹2,607.51 in December, reflecting an overall growth of approximately 19%. This growth percentage indicates that Torrent Pharmaceuticals is striving to maintain positive momentum despite market volatility.
Investors are advised to closely monitor the company’s performance, financial results, and industry dynamics to make informed investment decisions. The pharmaceutical sector is influenced by various factors such as regulatory changes, product developments, competitive landscape, and overall economic conditions, which can impact the share price.
TORRENT PHARMACEUTICALS SHARE PRICE PREDICTION 2026-2030
| Year | Maximum Price | Minimum Price |
| 2026 | ₹2,372.83 | ₹1,660.98 |
| 2027 | ₹2,016.91 | ₹1,411.83 |
| 2028 | ₹3,630.43 | ₹2,541.30 |
| 2029 | ₹7,457.47 | ₹5,220.23 |
| 2030 | ₹8,304.91 | ₹5,813.44 |
In the year 2026, the share price ranged from a minimum of ₹1,660.98 to a maximum of ₹2,372.83.Moving on to 2027, the share price experienced a narrower range, with a minimum of ₹1,411.83 and a maximum of ₹2,016.91.
The year 2028 saw significant growth in the share price, with the range extending from ₹2,541.30 to ₹3,630.43.Continuing to 2029, the share price further surged, reaching a maximum of ₹7,457.47 and a minimum of ₹5,220.23.
Finally, in 2030, the share price continued its upward trajectory, with a range between ₹5,813.44 and ₹8,304.91.
These historical share price trends indicate that Torrent Pharmaceuticals experienced substantial growth over the years, presenting both potential opportunities and risks for investors. The pharmaceutical industry’s performance and other market factors are likely to continue influencing the company’s share price in the future. Investors should stay vigilant, conduct thorough research, and seek professional advice while making investment decisions in the pharmaceutical sector.
FINANCIAL CONDITION OF TORRENT PHARMACEUTICALS :LAST 5 YEARS
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
| Sales | 7,673 | 7,939 | 8,005 | 8,508 | 9,620 |
| Expenses | 5,690 | 5,769 | 5,524 | 6,077 | 6,778 |
| Operating Profit | 1,983 | 2,170 | 2,480 | 2,431 | 2,842 |
| OPM % | 26% | 27% | 31% | 29% | 30% |
| Other Income | -300 | 121 | 57 | -288 | 45 |
| Interest | 504 | 451 | 353 | 255 | 333 |
| Depreciation | 618 | 654 | 658 | 662 | 707 |
| Profit before tax | 562 | 1,187 | 1,526 | 1,226 | 1,847 |
| Tax % | 22% | 14% | 18% | 37% | 33% |
| Net Profit | 436 | 1,025 | 1,252 | 777 | 1,245 |
| EPS in Rs | 12.89 | 30.28 | 36.99 | 22.97 | 36.79 |
| Dividend Payout % | 66% | 53% | 47% | 105% | 60% |
There has been consistent growth in sales over the years, with revenues increasing from ₹7,673 million in March 2019 to ₹9,620 million in March 2023.Operating expenses have fluctuated but have generally shown an upward trend. They rose from ₹5,690 million in March 2019 to ₹6,778 million in March 2023.The operating profit has shown overall growth, reaching ₹2,842 million in March 2023, despite minor fluctuations in certain years. Operating Profit Margin (OPM %): The operating profit margin has been relatively stable, fluctuating between 26% and 31%, with the highest margin recorded in March 2021.
The company experienced fluctuations in other income, with negative values in March 2019 and March 2022. However, there has been some recovery, with other income reaching ₹45 million in March 2023. Interest expenses decreased over the years, falling from ₹504 million in March 2019 to ₹333 million in March 2023.Depreciation expenses have remained relatively consistent, with a gradual increase from ₹618 million in March 2019 to ₹707 million in March 2023.
The EPS has followed an overall upward trend, increasing from ₹12.89 in March 2019 to ₹36.79 in March 2023. Dividend Payout %: The dividend payout percentage varied, reaching 105% in March 2022, indicating a higher payout than the net profit for that particular year.
Overall, Torrent Pharmaceuticals has demonstrated growth in revenues and profitability over the years, with some fluctuations in expenses and profit margins. Investors should consider these financial indicators alongside other market factors when making investment decisions.
FAQS
How Has Torrent Pharmaceuticals Performed In Terms Of Sales Over The Years ?
There has been consistent growth in sales over the years, with revenues increasing from ₹7,673 million in March 2019 to ₹9,620 million in March 2023.
What Has Been The Trend In Torrent Pharmaceutical’s Earnings Per Share (EPS)?
The EPS has followed an overall upward trend, increasing from ₹12.89 in March 2019 to ₹36.79 in March 2023.
What Is The Share Price Target Of Torrent Pharmaceuticals For 2025?
Torrent Pharmaceuticals share price might reach around ₹3,390 by the end of 2025.
What Is The Share Price Target Of Torrent Pharmaceuticals For 2030?
Torrent Pharmaceuticals share price might reach around ₹8,304 by the end of 2030.
Is Torrent A Good Share To Buy ?
Torrent is considered an appealing long-term investment choice due to its strong presence in various sectors and a consistent history of financial expansion, though it is essential to acknowledge the inherent risks that come with any stock investment.
Also Read:
- ZEE ENTERTAINMENT ENTERPRISES SHARE PRICE TARGET OF 2024,2025 TO 2030
- SUPREME INDUSTRIES SHARE PRICE TARGET OF 2024,2025 TO 2030
- HINDALCO INDUSTRIES LTD SHARE PRICE TARGET 2024 TO 2030: CAN HINDALCO REACH 2000 INR?
- CG POWER AND INDUSTRIAL SOLUTIONS SHARE PRICE TARGET OF 2024,2025 TO 2030
CONCLUSION
Torrent Pharmaceuticals, a significant player in India’s pharmaceutical sector, is recognized for pioneering niche marketing and maintaining a diverse presence in medical fields. With world-class manufacturing facilities and a global footprint across 40 countries, the company consistently achieves growth in sales and profitability, backed by a robust operating profit margin. Torrent Pharmaceuticals’ focus on generic formulations and strategic positioning contributes to its industry prominence. While presenting a promising long-term investment, potential investors should be aware of external factors such as regulatory changes and economic conditions. Seeking professional advice is recommended for a comprehensive understanding of the company’s performance in the dynamic pharmaceutical landscape.
Leave a Reply